A month has gone by since the last earnings report for Penumbra (PEN). Shares have lost about 10.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot ...

The medical device specialist completed enrollment for a clinical trial of its latest thrombectomy product. This addresses a significant medical challenge at a time when the U.S. population is aging.

Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session ...